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THE STANFORD UINIVERSITY BIOMEDICAL APPLICATIONS TEAM
701 Welch Road, Suite X3303
LI Palo Alto, California 94304
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PREFACE
This report summarizes the activities of the NASA Biomedical Applications wf
Team: Program at Stanford University for the period from October 1, 1976,
through December 31, 1976.	 This program is under the direction of Donald
C. Harrison, M.D., Chief of the Division of Cardiology at the Stanford Uni-
versity School of Medicine.	 The Stanford Biomedical Applications Team
' Program is supported under NASA Grant No. NGR 05-020-634, and its technical
Y r= monitor is Harold Sandler, M.D., Chief of the Biomedical 	 Research Division
a at NASA-Ames Research Center.
t For the convenience of the reader, the names and addresses of medical
device manufacturers referred to in this report are included in Appendix B.
This listin .g does not constitute an endorsement by either the National
Ae-ronautics and Space Administration or the Stanford University School
LI
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ABSTRACT
This report covers the major efforts of the Stanford Biomedical Applications
Team Program at the Stanford University School of Medicine for the period
from October 1, 1976, to December 31, 1976. This program is supported
I^
	
L	 under NASA Grant No. NGR 05-020-634, and its technical monitor is Harold
	
q	 Sandler, M.D., Chief of the Biomedical Research Division, at the nearby
NASA-Ames Research Center. The director of this program is Donald C.
Harrison, Chief of the Division of Cardiology of the Stanford University
S,chool of Medicine. During this reporting period, the Stanford BATeam,
e	 With -the help of scientists and engineers at the Ames Research Center,
has made significant progress on a variety of aerospace technology projects.
!s The proceedings of the NASA-sponsored Third International Symposium on
B,,iotelemetry, which was held in May, 1976, in California, have been
published during this reporting period. This 381-page reference text is
,;.	 entitled Biotelemetry III, _edited by ` Thomas B. Fryer, Harry A.-Miller,
and Harold Sandler, M.D. and is now available through Academic Press, Inc.
A significant milestone during this quarter has been the delivery of
six intracranial pressure transducers, complete with accessory telemetry
k ;	 . instrumentation. Laboratory evaluation of this intracranal pressure
monitoring system is now under tray in the neurosurgical laboratories at
Stanford University. Although this system is not yet ready for patient
I	
application, the manufacturer has made this equipment conmierci a 11 y avail-
k	 able for investigational purposes.
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Clinical evaluations of lower body negative pressure testing are continuing LL
i
at Stanford University Division of Cardiology. 	 Modifications to a	 leg
negative pressure device borrowed from the space program arebeing implemented
—
to make this unit suitable for patient trials in the Cardiac Catheterization
C 8
Laboratory.
Meetings between NASA engineers in the Manned Vehicle Research Division
w{r.
at the Ames Research Center and rehabilitation engineers at the Stanford }
Children's Hospital	 have been held.	 These meetings have led to a proposal..
for applications of aircraft communications technology to the development
of a synthetic speech prosthesis for patients with cerebral 	 palsy. l'
.i
The echocardioscope commercialization project has suffered a set-back due I
t . to the merger of Rohe Scientific with the North American Phillips
4 Corporation.	 Other potential manufacturers have been contacted and new
negotiations are planned. 1
A new Doppler blood flow instrument, initially developed for biomedical
research	 theat	 NASA-Ames Reasearch Center, has led to a successful commercial i
'i venture for the L & tit Electronics Company'.	 More than fifty of these systems,
I have been sold nationwide-.
a During this reporting period two new problem statements have been received:
x^
1) medical research applications of microwaves and 2) 	 tympanic membrane stereo
photographic	 mapping.
The QATeam is assisting with clinical evaluation of the NASA-patented
lanophor"	 a laboratory instrument for the analysis of serum proteins. ^?
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THE BIOMEDICAL APPLICATIONS TEAM CONCEPT
^ U
The Technology Utilization Program
I,. Biomedical Applications Teams	 important	 in therepresent an	 element	 overall
NASA Technology Utilization Program. 	 The Technology Utilization Program
began`in 1962 and was established for the following purposes:
ii
1,.	 To increase the return on the national 	 investment in
aeronautical	 and space programs by helping to bring about
additional	 uses of the knowledge gained in these programs.
^' Ll 2.	 To shorten the time from development of nevi knowledge to
its effective utilization.
a
^ 3.	 To aid the movement of new knowledge across organizational,
disciplinary, and regional 	 boundaries.
q
I, 4.	 To help develop better methods for communicating and
applying government generated knowledge to private industry. 	 -
3
The  Biomedical Applications Teams
{,. Biomedical Applications Teams (BATeams) were established by NASA in 1966
for the specific purpose of transferring aerospace technology to the solution
z gyp: of biomedical problems.	 Basically, the BATeam acts as an interface between
medical	 researchers and NASA engineers.	 Tema members meet with i nvesti -
£' ga^tors in the medical	 and biological sci ences to define significant
technological problems.
	
Only those problems are considered which meet
t the following criteria:
1	 No ready solution is available through commercial
x medical	 instrument manufacturers.
°i
I 2.The	 roblem can be defined in terms such that an
^r aerospace related technology could be applicable to
a solution.
p
l^
t
.^•^y
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3.	 Solution of the problem would make a significant
4
contribution to medical 	 research or clinical medical
practice.
^^ x
There are three Biomedical Applications Teams established at the following
institutions:
1.	 Stanford University School of Medicine
Cardiology Division
Biomedical Technology Transfer
701	 Welch Road - Suite 3303
Palo Alto, California	 94304#
' 2.	 Research Triangle Institute
P.O.	 Box 12194
Research Triangle Park, North Carolina 	 27709
1 3.	 Advisory Center for Medical Technology and Systems
University of Wisconsin
1500 Johnson Drive
Madison, Wisconsin	 53706
'i
Technology Transfer Process
i. There are many different ways in which technology developed through the
space program can be applied or transferred to solving biomedical problems.
The term technology itself is very broad, including both hardware and 'u=`
software, as well as the engineering expertise that has been a part of r
aerospace projects.	 No single approach to transferring technology to
medicine is applicable to all medical	 problems.	 The approach must be adapted 4
to the particular problem and the institutions that are involved.	 However, nR
. a
the general procedure followed by all the Biomedical Applications Teams
is asp follows
Fi rst a BATeam member confers with the problem originator.
Clarification of technological aspects of the problem leads }^M
N
"problem
	
".to the formulation of a	 statementBesides ...
p
f z
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a
defining the problem in greater detail, the problem
i.'	 statement answers the followning questions-
1. What medical specialty is involved?
2. Now has this problem been solved in the
past?
3.	 What presently available commercial
l
^._ equipment	 is	 applicable?
c
4. '	 [ghat broad-based medical 	 impact will k
solution of the problem have?
5.	 Can the technological solution offered
I by NASA be readily made commercially
available? r
{ r Answering these questions frequently requires computer searches
i
i of NASA data banks and direct contact with scientific and
engineering staff at the "NASA Field Centers.	 Circulation of
i problem statements among NASA scientists and engineers fre-
x
q;uently results in unexpected and novel 	 app-roaches.	 Finding
Lill tha t a solution does exist within the NASA program, the processr,
of technology transfer has just begun.
I'f	 after careful	 screening,	 a problem is found to be of
' sufficient medical	 significance and has potential	 NASA techno-
^	 ,;;: I	 ^ to i.cal solution	 the QATeam atte mpts to implementg	 lement or transferp	 p
this	 aerospace solution to the medical 	 field.	 Ins trUMentation
ION
r^
{ originally designed for the space program can seldom be
directly applied to a biomedical 	 problem.	 It must be modified
for its new
	
research	 laboratory or clinical application in
the hospital.	 Usually the medical	 problem originator
1 C'
r
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r
needs assistance in modifying and implementing the NASA
technology.	 A NASA instrument may requit-e adaptive engineering
or redesign of its capabilities before its feasibility in solving
IPL z
a medical problem can be demonstrated. 	 This problem of adaptive j	 l
engineering is a significant one and frequently requires the
r	
material, as well	 as engineering resources of a NASA field
v	 center or medical 	 device manufacturer.	 The prototype device
must then be clinically tested to demonstrate that it meets
specified engineering and medical standards.
	
Scientific
papers must be presented at major medical and engineering
-	 i	 symposia and published in leading medical journals in order
k -	 for-the new technological	 solution to gain acceptance.
One of the more recent goal's of the Biomedical Applications Team Program
is to increase the availability of the NASA solutions Through commercial-
'	 izafion.	 After a biomedical problem has been screened and a unique NASA R
^	 technological
	
solution has been found, the use of this technology by other
medical	 investigators and institutions' must' be considered. 	 If the original l
3	 problem has been carefully selected, there will be medical device manufacturers
r.6
interested in the NASA solution.	 There are many criteria which enter into
the decision as to whether or not medical 	 device manufacturers will accept
the new idea.	 Certainly profitability and the results of market studies-
-	 areimportant considerations.	 If 	 companys interested in th.einnovation,
} 3NASA can then grant the company a license to manufacture and sell the _device.'w
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GENERAL NEWS ITEMS AND TCAM TRAVEL
New Biomedical Applications Team Personnel
i Robert J. Debs is now a part-time technical consultant to the Stanford i
BATeam. He received his PhD in physics from M.I.T. and has been working
in instrumentation-related projects at Ames Research ,',enter for the last
_
thirteen years. Bob was a Branch Chief in the Saace Flight Research
Division, specializing in electromechanical instrumentation. He has
	
"	 recently retired from NASA and is assisting our team in two areas:
	^.	
1) he is helping coordinate the intracranial pressure monitoring systemfi
	
'	 project and 2) he is assisting with applications of liquid cooled garment
}	 technology at various medical institutions.
r
Steve Corbin, PhD is a bioengineer assisting with the laboratory evaluation
Of the intracranial pressure monitoring system. He is responsible for
U1 testing and calibrating the intracranial pressure transducers, as well as
developing a mini-computer-based physiological monitoring system for
-	 a
handling and displaying the experimental data.
Ei
Gene Fauro is. the BATeam secretary. She has had secretarial and adminis
1
trative responsibilities with a large ,real estate development group in
California and, also, has been a medical secretary and assistant to a
private physician, as well as secretary to the Medical Director of Project
HEAR in Palo Alto, California.
rf
i-13-`
a Awards
j. Gerald Silverberg, M.D., Assistant Professor of Surgery at Stanford !
University, one of the two principle investigators on our intracranial
pressure monitoring project, has recently received the Mellon Foundation
Award.	 This award is presented to ten scientists persuing careers in
teaching and research at the Stanford University School 	 of Medicine.
The award is to assist post-doctoral scholars who have demonstrated
vjt
- achievement and exceptional 	 promise in continuing their research and
teaching careers.
t+
BATeam Travel and Visitors
$. Gene._.Schm-dt attended a conference on	 image processing technology` . at
the California Institute of Technology (November 3,
	
1976).
*	 Robert Debs and Gene Schmidt reviewed progress on fabrication of the
^,	
a
F
intracranial pressure monitoring system atKonigsberg Instrument, 	 Inc. k
in Pasadena, California (November 3,
	
1976).
!4 * Gene Schmidtvisited the Jet Propulsion Laboratory, Pasadena,
x California (November 4,	 1976).
^l
Douglas O'Nandley, Manager of Biomedical Systems, provided
information on the proposed medical 	 image analysis facility
q (MIAF), as well	 as a tour of the JPL laboratories involved
a in computerized image processing systems. 	 Gene Schmidt
also met with Gilbert Lewis to review his miniature force
{ transducer fabrication facility and to plan for the
institutional transfer of this technology to the Stanford
f. University Division of Cardiology Animal Research Laboratory.
*	 Visit of Harry Miller to the NASA-Lewis Research Center,
ax
Ohio (November 11,	 1976).
G
r-19-
t
MYr	 Hiller was taken on a tour of the various research
facilities at Lewis by Mr. 	 Paul	 Foster, Technology
Utilization Officer.	 Subsequently, Mr. Miller reviewed
the operations of the Stanford University BATeam and showed
the film,	 "Dividends	 From Space - Biomedical 	 (applications
of Space Technology".	 Lewis personnel	 attending this
meeting included Walter T. 	 Olsen,	 Director of.TU and
= Public Information Officer; !•William t•icGannon,	 IM.D.,	 who
;j is an eye surgeon and inventor • of the ophthalmic micro-
surgical	 liquefaction	 ptn.rp
	
which is being developed at	 -
N Lewis; Michael	 Seaver, electrical engineer; and Gary Kelm,
'	 r a mechanical engineerwho has been newly assigned to
medical	 engineering projects.
This group had an in-depth three hour discussion of how 1
4 : the Lewis Research Center might become more involved in
biomedical activities. 	 Although, Lewis's major emphasis
N' is	 in aircraft propulsion, 	 including engine design and
<< power plant testing, there are the following potentials
lu
for work in biomedicine which should be cultivated:
1.	 They have extensive experience in materials z
research and testing.
2.	 They have done workin pressure and flow 1
4 using a variety of transducers. k
3.	 They ar-e prominent in the field of telemetry
systems.
4.	 They have both facilities and interest in
Y
telecommunications, using orbiting satellites.
x 5.	 They have an experienced and active TU
office, with engineering and administrative
know -how.
G
f.	 They have established effectivemechanisms'
within their center to allow -research
scientists to work on various biomedical
projects.
7.	 In-house money is available to do basic
engineering and problem-solving.rn
3.	 Although they do not have a Life Sciences
Directorate,they have a great deal of
interest anti motivation to apply their
r	 .
engineering technology to the field of
biomedicine.
TO
i
It is expected that this visit will
	 lead to the involve-
ment of our team and the other biomedical applications
teams to undertake new biomedical projects with Lewis.
This visit by Mr. Miller to the Lewis Research Center is
C the first of an ongoing program of travel by our team
c to NASA field centers which have interest and capabil-
t f ities	 in the medical	 field.
I Travel Next Quarter .4
€ f^ QATeam representatives will be makingpresentations at two bioengineering
conferences next quarter:
i
w^
1. The San Diego Biomedical Symposium
San Diego, California .l
February 2 through 4, 1977
S
g,
2. The Association for the Advancement of Medical
	 Instrumentation
(AAMI) l
4'. San Francisco, California
March 13 through 17, 1977
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INTRACRANIAL PRESSURE f O-NITORING
# Background
i
Th_e human brain is bathed in,	 and partially supported by, a constantly
circulating clear liquid called the cerebrospinal	 fluid.	 Should they
r brain suffer a severe insult (from a blow to the head, infection, or
tumor), the fluid pressure (called the "intracranial pressure" or "ICP")
,'t# increases; the ICP may also rise duri.n,g recovery from brain surgery and
i nl chi 1 dren with hydrocephalLI S.
Ifi the ICP increases too much, the brain suffers irreversible damage. µ
h It would, therefore, be of great use if ICP could be measured accurately
and continuously, with minimal 	 patient risk over a long period of time, -^
so that known medical	 and surgical techniques capable of controlling ICP
n
F
` could be called into use if necessary.
b
T Under a NASA Biological Applications Team Grant, the Stanford University m ;3
School	 of Medicine and the NASA-Ames Research Center are working -; 	 I '^
r` 
` cooperatively to produce such a system.	 Starting with an Ames-daveloped
ca acitative p ressure transducer, carrying its on-board electroP	 nics and ^=
i
F.	
V antennas to telemeter the intracranial	 pressure, they have contracted the
fabrication of the first commercially manufactured systems.
Approach
? ,
The pressure transducer,alith its attached antenna,	 is mounted in a small
burr hole drilled through the skull. 	 The transducer diaphram is positioned
co-planar with the outer lining of the brain.	 The scalp is	 then closed
. -.-. a	 •.
. 	 `^wiimsm,._-.s,o..^i,^.. ..L.^.h^.r^._,.r....aaa_.♦....^re^2.:ieei..ri.3n:.v.Wn.?':mn..rz...v._._ar._r_.s.:al a-. 	 L,a dw..<'e .^.♦..es,.+..x.. 	 ^u....x	 _f"u:..	 ..	 _	 .._	 ..	 ..,..	 __. _..,. ti..e c. 	 ._e-.	 ra	 xt. ^a^..^,Rw°-.;p'
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over the unit. The p ressure signal is telermetered to an external receiver.
In this Tray, wires penetrtrti ng the scalp, with the probable chance of in-
fection, are eliminated.
The implanted transducer/transmitter electro,iics are powered by an external
energizing coil, thus, eliminating problems associated with batter y failure.
(See Figure ..1)
EXTERNAL
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75 NW, DIA.
i
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i
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ICP t1onitorinq System
[Iounting Bracket
(with self-tapping screws) ^^ l
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j	 Quarterly Progress
The first six commercially manufactured systems were delivered on December
30, 1976, by the Konigsberg 1nstrU'ilent Company and are currently under-
"	 going long-term drift tests. The commercial model is made of titanium,
a metal having little or no reaction with body tissues or fluids; non-
.	 weldable seams have been sealed with an epoxy compatible with the body;
electronics are improved; and a single antenna, rather than the original
pair. of antennas, is used. 	 (See Figure :--2) Two transmitting/receiving
(external) powering units were also received.
Transducer/Transmitter;
Threaded Fitting	 ^.
iJ
!1
^l
Protective Casing
(for shipping and handling)
FIGURE -.?
Transducer/Transmitter and Fitting Accessories
a	 "
-28
Part of the calculator/computer auxiliary equipment (designed to record,
x
correlate,	 and present the telemetered pressure data tivith other vital
blook	 barometricdata, such as	 pressure,
	
pressure, partial	 pressure of
a blood gases, and temperature) has been delivered, and the remainder is
r
on order.	 Programming nor data handling and reduction has been started.
1
Plans
In order to meet requirements of both NASA-Ames and Stanford University
School of Medicine Human Research Committee approval, the following
tl L system of validation protocol will be followed:
z'
1..	 Establish the drift characteristics and calibration curve
for each of the six transducers - two to three weeks.,-
2. 	 contamination with known bacteria, one of the units 	 r
will	 be gas sterilized and then cultured to demonstrate
that -sterilization was complete.
3.	 This unit will	 be rechecked for drift and calibration
changes - two weeks.:
4.	 Lnplant chronically in animals to record performance
in vivo and to rule out tissue/fluid reaction - one to
=!' two months.
5.	 Re= check units for drift and calibration after removal
=' from animals.
6..	 Upon satisfactory completion of at least three chronic'
animal
	 implants, applications in selected patients will
— begin,
- Pers onnel
7 Principle Investigators:	 Gerald Silverberg,Assistant Professor of Neurosurgery
Stanford Medical	 School'
a	 '
;. Allen Ream,
	
h1. D.
Assistant Professor of Anesthesiology
:- Stanford Medical School
i-29-
BATeam Bioengineer:
	 Steve Corbin, PhD
BATeam Coordinator:	 Robert J.	 Debs
- NASA Engineer:
	 Thomas Fryer
Assistant Chief of Electronics
Instrument Development Branch
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,x CLINICAL EVALUATIOi`l OF LO'.-IER BODY NEGATIVE PRESSURE (LBNP) i
=t Background
;r L' Cardiologists have developed many tests to evaluate heart diseases.
;. The most commonly used cardiac stress test is the treadzri'll
	 ECG in $
b.
i} which aatient exercises as his electrocardiogram is
	 recorded a dp	 c	 n
kobserved for signs of decreased coronary blood flour.
	 In addition,
cardiologists evaluate the left ventricle (the major pumping 	 chamber
of the heart) by examining ci ne-angiograms (x-ray motion pictures of
UO the heart) taken during cardiac catheterization. Cardiac cathether-
4	 'r ization requires the passage of a flexiable tube or catheter through
f ' a major blood vessel	 until	 it reaches the heart.	 Radio opaque dye is
,. • c	 i	 the he	 d	 motion picture x-ray is	 recorded.	 This^nde.ted nto	 ^ 	 ^ art an	 a	 tion p	 ^e	 	
procedure is uncomfortable for the patient, time -consuming, expensive,,
fand involves	 certain risks.	 An alternative, non-invasive approach to
measuring left ventricular function would provide a very useful 	 test for
f^
`
evaluating cardiac patients. 	 Stanford cardiologists are evaluating LBNP1
4 as a new type of cardiovascular stress test.
Procedure
Lower body negative pressure testing requires placing the lovier half of
the body in a vacuum chamber.	 With waist-seal	 in place, the chamber
is then evacuated in stages.	 As the pressure within the LBNP unit is lowered,
some of the normally circulating blood is pulled down into the legs and
f
"
pelvis.	 The amount of this pooling depends on the pressure level or
suction.
r
t
C
-31-
Pooling of blood in the lower body causes less blood to be returned to
the heart.	 In response to receiving less venous return, the heart beats
r	 faster and contracts more vigorously to maintain output and blood
t	 pressure.	 In essence, the LBNP test provides a means for observing the
r
Cardiac response to decrease in venous return.
s
During an LBNP test the heart rate,
	
electrocardiogram, and cardiac dimensions
(determined using echocardiography) 	 can be monitored non-invasively.	 This
#i
'	 test, therefore, holds promise for providing a totally non-invasive method
of determining left ventricular function. 	 The non-invasive measurement of
E	 blood pressure and heart volume would allow the cardiologist to determine
ventricular function curves to help _document the improvement or worsening 	
M^
rof a patient's condition.
N SA Technology
LLNP was used extensively in the space program to evaluate the cardio-
vascular system of astronauts.
	
As long-duration space flights _became more 	 7
common, the time dependent deconditioning effects of weightlessness bacame
increasingly apparent.	 Flights as brief as three days caused some	 _<
astronauts to-faint-on return to earth and standing up against the full 	
s
r	 force of gravity.	 In order to study the cardiovascular changes occurring
h..w 
EE.
	
during zero gravity, LBNP chambers were used in the pre and post-flight 	 k»	
a
k	
evaluation of Appolo astronauts and for in-flight evaluations aboard
Skylab.	 This NASA experience with normal young volunteers has made it
now feasible to extend this technology to evaluate 'older normal subjects
and cardiac patients.
9	
^	 `f
. i ,. iw v'.y-yn^
''m^Tn+^^'^ '11.4'vL jnxx 	fix,.
ct
a'Q3v,`
.wWra
. ''
.wiw^M
G
t
Rrogress
During this reporting period a plexiglass leg negative pressure (LNP)
Lill unit,: which has been modeled after a pressure chamber, loaned to us by
Roger Wolthius., M.D.
	 and Robert Johnson of the Johnson Space Center in
t	 :' Houston,	 has been evaluated using several
	 normal volunteers.
	
Subsequent
2
{ to setting upthis
	 LNP uni"t in the Cardiac Ca thete: ''IZat1U?1 Laboratory,
µ under the direction of Edwin Al derrran, 1M. D. , it was suggested that the
thigh seal apparatus could be improved.
	 The improvement suggested by
Doctor Alderman will allow the L`1P unit to be more readily adapted to
patients of different sizes.
	 Cardiology Division Engineering personnell
are now supervising these suggested changes in the LNP unit.
	 The machining_-
will be done at the Stanford University Astroaeronautics tiachine Shop
a	 a
early next quarter. 3
Plans
 i
On completion of the improved leg negative pressure units, a clinical 4
UP
a
evaluation will	 resume.	 After the improved unit is validated using normal
'U'
volunteers, the first cardiac patients will be selected for examination in
f
;t
,
the Cardiac Catheterization Laboratory.
	 Selected patients who have
S•
A	
r
. previously had intramyocardial markers placed at the time of open heart ^^';?
surgery will	 be studied.	 These are patients who have had small 	 tantalum
markers placed in the walls of their heart during previous open heart
1
' } surgery for either cardiac transplant or coronary artery bypass graft surgery
purposes.	 The presence of these radio- opaque
 myocardial	 markers will	 allotiv f
lF accurate determination of ventricular vole	 rres .	 Decreasing the pressure )
in the LNP units in serial
	
stages	 Will	 cause decreases	 in left ventricular
i
jx
k4
FI	 ^
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volume.	 This reduction in volume will	 be quantitated using a computerized
1.
s^Istem developed at Stanford under a NASA grant.	 Comp arison of volumes r
measured echocardiographically will 	 be made simultaneously for comparison.
This data, coupled with the arterial blood pressure, will	 allow determination :z
of whether or not this technique will be useful in catheterization studies
° and cardiac drug intervention studies. it
Personnel ix
Principle Investigators: 	 Richard Popp, M.D.
Assistant Professor of Cardiology
t
Edwin Alderman, M.D.
Assistant Professor of Cardiology ,f
BATeam Coordinator:	 Gene Schmidt, M.D.
! Cardiology Physiolo g ist:	 William Haskell, PhDx ^.
i Engineering Technician: 	 Cecil	 Profitt
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PORTABLE SPEECH PROSTHESIS FOR PATIENTS WITH CEREBRAL PALSY-
Objectives
To apply NASA technology and expertise in the field of speech synthesis
systems to the communications problem of speech-impaired cerebral palsied
patients. To demonstrate the applicability of NASA technology to this
problem by constructing a wheelchair-mounted s peech prosthesis which
utilizes research results, computer programs, and communications systems	 1
l
expertise derived from the Ames-Research Center, Flight Management Systems
Program.
rt
Justification
For patients who cannot speak or use their hands and arms for writing or
s `	 sign language, some means of communication is crucial to satisfy their 	 r
basic physical and intellectual needs. There are approximately 500,000
patients fitting this description who could profit from the use of better
	
F
comunications systems. Included in this statistic are patients who have
had a stroke and victims of an accident resulting in a high level spinal
cord injury. Although applicable to these different categories of patients,
5	 t e speech prosthesis described in this proposal will be used initially by I^
piatients who have cerebral palsy.
Cerebral palsy is a type of neurological disease which results in major
disturbances of motor function and has usually been present since infancy.
	
r
.1
The resultant motor abnormalities are numerous and diverse, 'often resulting
in difficulty `in controlling the muscles involved in speaking, walking, and
writing. Although the cerebral palsied patient's sensory and thought
	
i
processes are frequently normal, approximately 20 percent (150,000) of these
I
35	 --
6 patients are intellectually and emotionally handicapped by the inability
to produce meaningful communication through either speech or writing. z
w
r Although parents or teachers familiar with the patient may be able to develop
,
some sort of a communications code or system, the possibilities for the
patient's interacting with strangers in the outside world is extremely limited.
k It is this latter area of communicating with persons outside of ,medical
` institutions or the immediate family that limits employability and self-
sufficiency.	 The objective of this^	 proposal	 is to apply NASA technology
to the construction of a synthetic speech device which is battery-powered,
small enough to be carried on a wheelchair, and which can be used by cerebral
palsied teenagers and young adults while working at their jobs and providing
for their everyday needs.
There is widespread interest among cerebral
	
palsy centers in providing
} better communications systems.
	
The Children's Hospital at Stanford has been
! inclose contact with other institutions (The Ontario Crippled Children's
C
g
Center in Toronto and the Trace Center at the University of Wisconsin) who
Ll
have confirmed the need for and provided assistance in developing specifi- r
cations for communications devices for the handicapped. 	 In addition, the
Biomedical Applications Team at the Research Triangle Institute has identified r'
a number of institutions on the east coast expressing the common need for
better communications devices.
	 Their contacts have included: 	 the United
C rebral Palsy Association of Nassau County, the Bernard Fineson Develop-
mental	 Center, and the `Gifted Handicapped Project, Divisions for Disorders x
of Development and Learning, University of North Carolina.
^>
!	 NASA Technology
This proposed technology Utilization project will employ technology and
expertise in speech synthesis systems developed by the t•1an-Vehicle Research
y
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' Division at the NASA-Ames Research Center. 	 Within that division at Ames,
a; there exists a Flight Management Systems program to investigate the use ,
u
of artificial
	
speech in cockpit communications of advanced aircraft.
	 NASA
{ scientists involved in this program include a San Jose State University
Foundation Research Associate in psycholinguistics. 	 They have been working
on the problem of utilizing voice messages generated by a speech synthesizer,
to'warn pilots of dangerous situations and aircraft malfunctions, and
providing verbal	 output for such variables as altimeter reading, air speed,
's and sink rate to the pilot whose eyes are busy monitoring aircraft attitude
and the approaching runway. 	 These investigators have wrtten numerous papers
' concerned with the intelligibility, ease of comprehension, situational
appropriateness, and alerting capability of synthetic voice messages which a
could be used in aeronautical contexts.
	 These same principles and approaches
already developed 'for synthesizing voice messages
	 in the cockpit are directly
applicable to a synthetic speech device for use by patients with cerebral
f
'
x
palsy.	 This group has had extensive experience with modifying P	 •	 9	 P	 P'	 y	 9 t,
intonation patterns, word choice and redundancy, to maximize the intelligi-
bility of synthesized speech.
	 In addition to providing an opportunity to
 r apply NASA aeronautical 	 expertise to this medical problem, this project 	 •rill
r
provide opportunities for new applications of NASA owned equipment (such as
.
the Votrax VS-6) which could be loaned by Ames for use at Children's Hospital
at Stanford.,
ri.
Approach
The synthetic speech solution proposed by NASA researchers to solve this
medical .cornnunications
	 problem will
	 require the design,
	 fabrication, and testing
diagramspeech prosthesis.	 As shownOf a trheelcharr-mounted spe ch-	 tm in the	 on the next
page,	 thi s , dQvi ce ' wi 11
	 consist of three major components i 	 a' user i rite r-
face (control device and visual display board), a microprocessor, and a
i
;a,.1	 A
^.
.^
^a
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,. speech synthesizer.	 This system will be portable to the extent that it can E
r
E? bei mounted on abattery-powered srjh eel chair. 	 It will make use of existing
Flight Management hardtr^are as much as possible and all 	 components will 	 be
driven from the tweny-four volt battery which is used to poster the wheel-
r ^ ^
- chair.	 The system will	 have a "vocabulary" of 100 words and phrases tailored
t tol the needs of the individual 	 user.	 Vocabularies specific to different
sijtuations and individuals will	 be stored on cassette tapes which can be
loaded into the system when a change in vocabulary is desired. 	 A phonetic
r	
y
7	 A
system will	 be used which includes simple rules for speech intonation and
stress patterns in order to produce highly intelligible speech. 	 This feature
willl result in greater versatility than a system which simply plays back
stored messages.
.. Since patients have varying degrees of control 	 of their arms and hands, it
.will be necessary to construct a versatile interface and control switch
' which takes advantage of the movement capabilities of the individual. 	 For
U example, one patient may have the dexterity to operate a joystick while
1 another patient is limited to simple on and off switches with large control
Y surfaces.	 The user will access desired words and phrases via a visual
j rdisplay matrix board of a type now commonly used in cerebral palsy centes.
By appropriate movement of the control switch, the patient will	 be able to
.• illuminate the square containing the words or phrases he wishes to say. 	 A
' serial interface will 	 translate the coordinates of the selected square into
I	 ' a digital	 code for the microprocessor.	 Based on this received code, the
microprocessor, using a Random Access ttemory (RAM) , will then select the
appropriate driving commands to activate the speech synthesis output device.
IF, Initially, programming will be accomplished on a PDP-12 computer at Ames and
kk fed into the microprocessor memory via a, paper-tape reader. 	 The versatility
i
. iyiiT	 - -	 `-1`."	 Sa^,^Sy' X" Y3d'eliBiNlYLar1.i^W ' 	 _r.,xa.re.. a._	 _ _ ^^..^..^. _	 ._ v
.-39-,
of this system will be enhanced in the future by programming the micro-
a processor-memory using selected cassette tapes containing the new
vocabulary desired. - Y.
Eq ui p meat •?	 '
1.	 Battery-Powered Wheelchair
Ai battery-powered wheelchair with rechargabl e battery will a
A provided by the Children's Hospital
	 at Stanford,	 Rehabili-
tation Engineering Center.	 It will
	 provide, not only the
power	 source for the speech prosthesis, but also a bracket -
attached to the arm of the chair will allow for mounting
the unit within easy reach of the patient.
2.	 User Interface
This consists of a visual
	 display matrix containing the
appropriate words and phrases.
	 Plastic overlays will	 allow
changing this matrix of words and phrases as needed.
	 In
addition, a user-activated switch will
	
illuminate	 indivi-
dual	 cells within the matrix.
	 This	 interface will be designed
within the engineerin g
 laboratory at the Children's Hospitalf at Stanford,and a variety of control devices wi ll make it x
operable by patients with different degrees of dexterity. a
3.	 Serial	 Interface
4
This interface between the vi sual display Matrix and the
microprocessor will be designed by an electronics engineering
consultant and built from purchased components by a part-
fi5
time technician. r
".
t.t 4:	 iii	
-
croprocessor
A variety of commercially available microprocessor, having
sufficient logic capability are presently available.
	 The
=. basic price of these is approximately 5500. 	 In _addition,
it will be necessary to purchase ;four cards of 16K memory
at $120 each:	 The mi cro p ro cessors selected will be M,
compatible with programs generated on NASA laboratory
^- computers and will be reprogrammable, using a paper-tape
reader Q200) and a cassette drive C5100).
•
5.	 Speech Synthesizer
u
µ
An essentiaY component in this proposed speech prosthesis
r. is a Votrax VS-6 speech synthesizer.
	
These sell	 for
k, approximately 53,000; however, we anticipate that a unit
will	 be available on loan from the Flight Management
ems Programfor use in this proj ect.Syst s.
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P1'ans
r 	 The Stanford BATeam wi ll
	be working with the Children's Hospital	 at	 !,	 ,
r
i	 Stanford and the tlanned Vehicle Research Division at Ames to make a formal
1
`	
proposal	 to NASA to allo;•r construction of a prototype to demonstrate the 	 1
feasibility of applyin g the flight management s ystems technology to this
.,	 9	 9	 y	 9y	 ^
rehabilitation problem.
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MI?dIAT(!RE C1IRDIAG FORCE TRANSDUCER
G
Objective
^ To utilize NASA-developed miniature cardiac force transducers to investigate
the effects of myocardial ischemia in laboratory animals.
L
Background
One very important research area in cardiology is determining the effects
of coronary arteryocclusion on the contractility of heart muscle.	 Knowing r°"
s
how heart muscle is affected by the sudden loss of blood flow through the
coronary arteries has direct bearing on the outcome of heart attack victims. 4§ lXY
' NASA Technology
f Several designs for miniature transducers which would be applicable to cardiac
research have been developed at the Jet Propulsion Laboratory (JPL), under
t NASA sponsorship.	 JPL scientists, R. H. Silver, G. W. 	 Lewis,	 C.	 Feldstein,
E.	 N.	 Durand, and J. C.	 Fletcher, have been issued a patent on the
transducer °depicted in the drawing below. ,tN
i Strain Gauge -<
t. Tines
f
arb
i E
u
r
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Tie miniature transducers would be one cm across and have tines from seven,
i to eleven mm in length.	 As shown in the figure, the tines would have
t :
barbs to secure_ there into the heart,muscle,and wires running from the
F
transducing element would provide a measurement of contractileforce.
r
Proposed" Appl i cati on
The Stanford University*Division of Cardiology has an NIH funded Program
`y Phoject Grant, entitled "Pharmacologic and Physiologic Basis of Cardiac
Therapy".
	
As	 this	 in investigating new 	 forpart of	 program	 modalities
treatment of heart disease, Stanford researchers are studying the effects
G ojf artificially produced ischemia in laboratory animals.	 Specifically,
the work calls for the recording of both myocardial	 contractile force and
I
regional	 "cat-dial electrogram" in open chested dogs during acute coronary
^
artery ligation.	 An array of six contractile transducers,serving the
`f
r
double purpose of providing a localized ECG signal, would be used to map
3
the "zone of ischemia" produced by sudden interruption of the blood float
u through the coronary arteries.
t.'
Problem Status
The Jet Propulsion Laboratory's proposal to NI ASA to make improvements upon
: an earlier design for the miniature force transducer has been
4 The, Stanford Biomedical	 Appl ications Team is viorki ng vii th Jet Propulsion
^.T
a Laboratory scientists to apply these miniature transducers to cardiology
'f phyarmacological	 research,'
Transducers furnished by JPL wi11 be used to study the effect of
r	 ,.
accepted and investigational	 pharmacological agents used in the treatment
I.
-43-
I
of heart patients.	 How these cardiac drugs affect contractile force and ^ }
the size of the heart muscles are important medical questions to be answered n ;.:
if one is to develop 
	 rational basis for treati ng heart attack patients.p	 g	
I
s
The required transducers are to be delivered to Stanford during the next
z
'I
' quarter.
4
t
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kACTIVE COINVEP,CIALI?ATIJ'^-?ROJECTS
i
Introduction
The overall goal of the NASA Technology Utilization Program is to ensure
i
the widest possible dissemination and utilization of•tethnology developed
r' through the aerospace program. An important wayin which technology can
!	 j;	 reach a large number of users is through the manufacturing, marketing,
And distributing capabilities of private industry. If there appears to	 i
-	 be a widespread need within the medical profession for a device based on
NASA technology, the Biomedical Applications Teams contact medical
instrument manufacturers to determine the feasibility of coirrmercialization.
a	 t^'
The medical device manufacturing industry is extremely competitive, and
for each idea which leads to a successful product line there are hundreds	 y
which rove to be commercially uneasible 	 One can t herefore, expect^ 	 p	 	 ^	 .F	 o  e''r 	
	 ^.
that only a small percentage of proposed technologica-1 solutions can ever
i
achieve successful large-scale commercialization. No,+ever, if the
	
j	 biomedical problems are originated by reliable medical investigators
	
_	 and the problems are screened for their potential to satisfy a significant
need in the medical profession, the likelinood of realizing a commercial-
izable NASA technological solution is increased.
The'Stanford Biomedical Applications Team has established numerous
7	 relationships with medical device manufacturers. Conmerciali`zation
	
1f	 ;
	
r`	 activities.for this reporting period are described below. 	 }
r.
,T
I
y
.	 w	 '
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1.	 NASA Echocardioscope
The BATeam has a grant from NASA to identify a medical device
manufacturer for the NASA-developed portable echocardioscope. a..
This instrument, which is under development at the'Ames
' Research Center, uses high frequency sound to make two IJ
l
dimensional	 images of the beating heart in real	 time.	 An
f
earlier version of this instrument was developed cooper-
a
ig atively by engineers at the Agnes Research Center and {
a
card,iologi_sts at Stanford University.	 A patent application
on the latest model,	 3-E, has been filed. 
Last summer the Stanford BATeam had a letter of intent
3 to, 	this instrument from Rohe Scientific-M
Corporation in Santa Anne, California.
	
Rohe had alsox.
applied for a non-exclusive manufacturing license through
the Ames Patent Office.	 A contract to design and
fabricate the first three commercial 	 prototype instruments` r
was prepared and sent to Rohe for their signature. 	 The
possibility of a pending merger between Rohe and North
` American Phillips Corporation prevented their- immediate
x
m
a
signing of this contract. 	 In November, 1976, the merger
I, of Rohe with Phillips was approved by the Federal 	 Trade
Commission.	 The ne%q management,	 under Phillips,	 has
decided not -to sign the commercialization contract.	 The
that they already hadmajor reason given was
	
a similar
linear-array echocardioscope under development.
y,
„, s
.`v
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r	
}; r' Subsequently, the BATeam has requested a no-cost extension
on the echocardioscope commercializati=on grant and has
ibegun making contact with other potential manufacturers.
Medical	 instrumentation companies which have expressed.
rz
interest in the NASA echocardioscope are:
r
A.	 Smith-Kline Instruments
v Palo Alto, California
F	 ?;
r B.	 Advanced Technology
4 Bellveue, Washington
t'
y
T
C.	 Searle Ultrasound
Santa Clara, California
A meeting with representatives of Smith-Kline Instruments
I
is scheduled for January, 	 1977. f
L 2.	 Intracranial
	 Pressure Monitor ing System
Ej
The_intracranial pressure monitoring system, consisting
of an implantable pressure transducer/transini ttee and an
fi external	 power source and I;F receiver, is now commercially ;.e
available from Konigsberg
	 Instruments,	 Inc., Pasadena,
an electronics(:alifornia.	 Konigsberg Instruments is
firm,	 specializing in advanced	 implantable instrumentation. J
Theis product line includes single and multi-channel
4
o
;. implantable telemetry systems,	 implantable accelerometers,
force transducers, and flow and ventricular dimension
measurement systems.
	
During this quarter they have l
i.
delivered the first six intracranial	 pressure transducers
l
for neurosurgical
	 application at Stanford University.
7.
which they have now con	 basedThe ;system	 -nercial •ized is
:a
}4
i ^ S
i
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on the design of Tom Fryer, telemetry systems design
ri
E
k engineer, at the NASA-Ames Research Center.	 Present
production of this system is limited since performance
validation studies have only recently begun at Stanford.
The manufacturer, however, is going ahead with the
product literature  and is making the system coninerci al ly
available for research purposes at this time.
3.	 Doppler Blood Flog Instrument
biomedical
^p
=^
i
Inl
^ 
the course of	 research	 Within NASA, new
^
instruments to monitor physiological	 perameters are being #	 t
s developed.	 Within the Life Sciences Division at the NASA-
..
Ames Research	 extensive	 investigations;Center	 cardiovascular
are currently unden-jay to measure and evaluate circulatory t:r
r` changes resulting from the stresses of acceleration and
zero gravity.	 Within the Biomedical	 Research Division at
Ames, new instruments	 •iere required for the non-invasive
-,
measurement of blood flow velocity. ^,	 3
L
	
& C1 Electronics,	 Inc.,	 Daly City, Cali' 	 was ^	 }
contracted to develop a new instrument for this purpose.
This new instrument uses high frequency sound (ultrasound}
to measure the velocity of circulating blood. 	 It makes
use of the Doppler principle, converting the backscattered
ultrasonic phase' and frequency information into an analog ..
signal, which is displayed on a'front pannel meter and
;^	
r
""w.
..
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1	 strip chart recorder. Both the average velocity and the
direction of blood flow at any mor,ent in time can be 	 i
measured.	 -
Besides satisfying the need for the space - related physio-
1 og i cal research underway at Aries , this i nstrument i s
gaining wide acceptance at institutions involved in both
E
research and clinical medicine. ;,ore than fifty instru-
ments have been slid to date. Apartial list of users 	 l
IJ
is given below:
-	 Oklahoma State University
Stillwater, Oklahoma	 3
-	 Peter Bent Brigham Hospital
Boston, Massachusettes
Providence Medical Center
Seattle, Washington
-	 Santa Clara Heart Association
San Jose, California	 3
s
University f Colorado Medical Centery	 F
Denver, Colorado
j'	 University of Michigan
Ann Arbor, Michigan
University of Texas
Galveston, Texas
-	 Baylor College of Medicine
Houston, Texas
I	 Duke Universi ty
Durham, North Carolina
Huntington Memorial Illospital
Pasadena, California
4i
S.
i'
ti
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^	 ^ w
-	 Mayo 'Foundation
Minnesota
y
Rochester,
-	 Veterans Administration Hospital
Dallas, Texas ..
4	 -	 University of Kentucky
( I	
Lexington,	 Kentucky
Doug Johnson,
	 Denver Research Institute, has been	 infori7ed
of this commercial	 transfer and plans to include it in the
"Benefits Briefing Notebook".
'	 4.	 Additional	 Activities
`	 During this reporting period Ray Whitten, Chief of the
Biomedical Applications Branch at NASA Headquarters,{
suggested that our BATeam might be able to identify„
potential manufacturers for NASA technology by contacting
e
i	
PP	 ^	 'NASA's	 Industrial	 Appl ications	 Centers.	 IAC s).	 The	 I^,G s r
have computerized access to more than one million technical
(	 reports in the aerospace field, as well	 as maintaining
the
	 data bank of scientific, engineering, and r
medical	 literature i
 in existence. ' 	 They provide a fee for
,a
service literature searching capability for industrial _ -d
clients.	 Because of their thousands of contacts with
both large and small	 companies across the nation, it is µ'° 1
anticipated that sale of their clients will 	 be interested
in commercializing NASA biomedical, technology being made
available through the BATeam.
is
c
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tIr cooperation with Janes Beebe at the NASA Scientific
i ' and Technical	 Inforr,ation Facility	 (STIF), the	 followingb
r.'
announcement, describing four instrumentation :projects, •
has been sent to Daniel :di 1 d,	 Director of the New
li
'
,'
England Research Applications Center (NERAC), and
Radford King,'Director of the Idestern Research Applications
r	 ^^
itt.
' Center (WESRAC).	 This announcement is to be included-in x	 y
their respective newsletters which are sent periodically r
i A.
to_IAC clients.
"The NASA Technology Utilization Program attempts ;r
' p romote the widespread use of NASA aerospace
x `
to
ethnology.	 One approach
	
is the commercialization
d
— of this technology.	 Inquiries	 are invited from
I manufacturers interested in developing the folloti•aing r
technologies into commercial	 devices.	 Some co-funding
^.; from NASA is possible, as t;e11
	
as non-exclusive and t
r
aPr exclusive licenses.
K;1, r
The Cardiology Division, Stanford University School
of Medicine, is under contract to NASA -to assist
in the transfer of technology to the biomedical
1 community.'	 Inquiries should be addressed to: -a
Gene	 Schmidt,	 i•1. D.
Assistant-Director - Stanford Biomedical
'
Applications Team
Stanford University School
	 of Medicine
{
701 Welch Road - Suite 3303
Palo Alto,	 California	 94304
(415) 497-6233
-'Cardiac Stress.Testing OevLice_
The Stanford University Iledical 	 School,	 Division
of Cardiology,	 is evaluating a; concept developed
by- -11ASA for determin ing the cardiovascular effects
of weightlessness
	
on astrO[Iaut	 .	 The concept
ernploys	 a.'vacuum chamber t ahicii	 is	 applied to the
lower half of the Subject being tested. 	 The
i
M.
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chamber is evacuated	 in serial
	 stages,	 resulting
in blood pooling
	
in the lovier half of the body
The individual's response to this orthostatic-
like stress	 is niani flested by changes	 in both
cardiac and vascular dynami cs.
	 Studies are pre-
sently unden^iay at Stanford University to
determine whether or not this type of cardio-
vascular stress test is applicable to 'the
diagnosis and treatment of patients with heart
disease.	 Used in conjunction with echocardiography, J,
this stress test is being evaluated as a means
of determining left ventricular function non-
invasively. 7
Synthesized Speech Prosthesis
Researchers wi th i n the Flight Management Systems
Program at the NASA-Ames Research Center are working
with rehabilitation engineers	 at the Children's
Hospi tal	 at Stanford, in the design of a synthetic
speech prosthesis.	 The speech prosthesis is
designed for use by patients who are unable to
Ce use of their hands andspeak and have inadequal
arms for wri t ten or sign language communications.
This device incorporates technology developed at
the Ames	 Research Center,	 to utilize artificial
speech	 in the cockpit commiunications of advanced
aircraft.	 Still	 in the conceptualization stage,
this	 device would use a visual	 display Piatrix
board for work and phrase input, a microprocessor
with random access memory, and a cominercially
available voice synthesizer.
Real-Time Detection and Data Acquisition System
for the Left Ventri cul ar Outl i ne J,
A Real-Time Contour Detec4' or and Data Acquisitions
System for the left ventricular outline has been
developed by NASA which utilizes	 video	 techniques. 1A.
The k­ray image of the contrast-filled left ven-
tricle is stored on film, video tape, or video disc
for subsequent processing.
	
The cineangiograrl
is	 converted,into video for^ 71at	 usina a	 television
camera.	 The
	 video si.g,nal,
	
froni either	 the T.V.
-ovides	 tcamera ,	 video tape,	 or ^disc	 pi	 -he	 i nput
signal	 to the system.	 The COntOUr detection process
is based on a dynamic thresholding technique.
Since the left ventricular outline is	 a sirooth .-J
"FWDUMILITY OF TUX
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I:e dicti^rMnESiw
in
tl
7
	 _r
1
is
-53- ,
E continuous function,
	 the contour	 IS	 tracked by
f; ^= defining	 a narrow expectation ,iindos-^ ;or the nett
j= point,based on the location of the precedinn,
point.	 A computer interface has been iCJiomed
and built for the on-line
	 deterr,iinatI
	
of the
coordinates of the border points,
	 utilizing a
' PDP-12 Computer.
	 The advantage.	 of this	 system
over other available systems
	 is	 its	 potential .
jfor real-time determination of the ventriCL11ar
o-
,. size ..and shape 	 during an iocardio	 ra hp	 g	 g	 _1	 p Y
Ji
Linear Array Echocardioscope i	 y
W This	 cardiac ultrasonic imaging device riakes
	
use z,^
of a-linear array of ultrasonic transducers. 3'1
E , F The anatomy of the heart is represented in real-
time, using the pulsed echo technique.
	
The
cardiac image can be represented in the A-Mode,
M-Mlode,
	 and	 '"C-Scan"` i•1ode.	 The
	
latter mode
results	 in a two-dimensional
	 cross-sectional A
image.
	 This instrument is
	 unique in offering
these three imaging modes in one portable Unit.'
Another important fe ature of this instrument is
F
z
its uti lization of. COS/"OS	 integrated  circuits
to minimize po;rer consumption and perrni t battery
operation.	 Although C-Mode display instruments
have been developed previously, they require a,,
4
' multiplicity of receivers, whereas this instru-
ment requires only one receiver.
	 A NASA patent
application has been filed."
I
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PROBLEM I.E. NUNBER: 	 BNL-01
Problem Title:	 Medical	 Research t?ppl•ications of Microwave Radiation
Date of Preparation:	 December 14, 1976
Institution:	 Brookhaven National	 Laboratories
	
- Long. Island, New York
Investigator:	 Daniel
	
M.	 Slatkin, M.D. '- Pathology
« BATeam Contact:	 Gene Schmidt, !•1.D.
Health Area:	 Cardiology and Oncology
Y
Background
{
Lb Doctor Slatkin would like to study the effects of reducing white blood
cell migration into regions of infarcted heart muscle. 	 In order to study .
Ul this phenomenom, he needs to induce non-lethal myocardial 	 infarcts -in z
F
small mammals	 (such as the rabbit)	 by non-invasive means.	 He suspects
that it may be possible to cause small	 regions of .heart muscle damage,
Y
r using focused microwave radiation.	 The local thermal effects of the 7
microwave beam would cause sufficient heating in a small zone of heart
muscle to result in tissue death and a pseudo-myocardial	 infarction.
Constraints and Specifications
' The desired zone of critical 	 heating should be one to two centimeters
in diaineter.	 It is desired that the depth of critical	 heating cause damage
only to the heart muscle and not to the overlying skin and chest wall.
Doctor Slatkin's preliminary calculations 	 indicate that`a microwave beam'
25	 1of frequency 20GHz to 80GHz, with an energy of	 to	 +D+D watts, could
loft
s
-n
r
-:5G-
produce the required zone of heart muscle damage within a ten-second
`. time period.
s'
E
Additional	 Information
Doctor Slatkin is also interested in the possibilities of applying focused
microwave radiation-to thereto-coagulate tumors in the lung and liver as
an adjunct to x-ray therapy.
a ^-
^r
What is Needed
The investigator would like some assistance in detennining whether or not
the approach he conceives	 is technologically feasible; i.e., can a micro-
s ; i x
k r
stave radiation- be focused_ on internal organs to cause discrete, non -lethal
,.
" zones of ti ssue damage? prt
1
r;
Status
This problem statement has been sent to allNASA	 technology utilization
offices	 and BATeams.
^rz
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jry
PROBLEM i . D.
	
NUi 18EP,:	 UFLA-01
Problem Title:
	
Automated Tyr,ipanic Membrane Stereo Photographic Mapping
Date of Preparation: 	 November 23, 1976
" En Institution:	 University of Florida College , of Medicine
` Investigator:
	 Marc S.	 Karlan, M.D. - Assistant Professor of Otolaryngology
BATeam Contact:	 Gene Schmidt, M.D.
Health Area:	 Ear Diseases and Computer Applications
2
Background ti	 ;
The normal anatomy of the tympanic ir^embrane (eardrum) is distorted by
N
increased or decreased pressure in the middle ear. 	 These abnormal pressures
'  tifectioncan ari se both from middle ear	 otitis media(	 }	 and Eustachian +#
tube disfunction.	 Presently, ear specialists record the degree of distortion .
of the tympanic membrane in the=patient's chart using either a written
description or a, free-hand drawing. 	 Doctor Karlan is in the process of
n developing an automated stereo photographic system for recording. the
three-dimensional	 contour of the eardrum.	 When operational, this automated ^;
system will provide an accurate and reproducible method for recording
x
tympanic membrane anatomic changes :•,-hich wi I l 	 be invaluable in the diagnosis
' and treatment	 tool.of patients and provide a very useful	 research
Constraints and Specifications
Doctor Karlan has a 7echnicon motion analyser for determining the X--Y
coordinates of the tympanic membrane through a magnifying otiscope. 	 He
j
lf
x	 ',II1
aleso has access to an ISM 370 Computer for deter°rnin ng the depth or "L -
coordinate through triangulation and producing a hard copy of the tympanic
membrane image.
Wh.a.t. is 'Neededx
Doctor
II,
Karlan expects that computer programis developed by NASA for topo-
$ ra hic mapp ing may be a p plicable to tympanic membrane map p ing.	 He wouldg ^ P	 PP	 Y	 PP p	 9 •-
;^
l
like to obtain a suitable general program which couldbe adapted for use
y
with the computer hardware he has available. t
Status
T'iis pi-oblem statement has been seat to all	 NASA technology utilization
offices and 3ATeams
	
for° review.
	 Possible application of the three-
dimensional measurement and display system developed by Cunninghari and ._
Yakimovsky will beconsidered.
M1
r.
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NEW MICROELECTROPHORESIS INSTRU•IENTATIO`d i
Background
Electrophoresis is 	 a laboratory technique for physically separating biologically i
important proteins using an electric field. 	 Different blood proteins vary
r
in size, shape, density, and electrical 	 charge, so that they migrate at
varing rates when placed in a suitable r7edium with an electric field applied.
b
The laboratory technique of electrophoresis has been in use for many years f
and has	 demonstrated_ its value in both clinical 	 and phroensic medicine. ; a
^; 1
NASA Technology
Benjamin Grunbaum, PhD, a biochemist at the University of California at
Berkeley, has been developing a new instrument and techniques for doing
electrophoresis for the past fifteen years.	 His work, funded in part by
NAM, has been in the development of electrophoretic techniques for use in
analyzing the serum proteins of Apollo astronauts.
	
Doctor- GrunbaLIM has .
recently invented a new device, which he calls the "Nanophore" ( "Nano"
specifying a very small 	 quantity, "phore"	 from the term "electro phoresis".)
a
This device includes an automatic multiple sample applicator, a novel
t
i
sample holder, and a	 radically redesigned electrophoresis	 apparatus. a
This instrument is being patented by tfASA, and six of these units are beiig
built for the Department of Justice for use in criminology laboratories.
0
3ATear7 I nvol vetnen t
Through Walter Goldenwrath, Ares-:7ESRAC Technical Coordinator, the Stanford
QATearn was informed of Doctor Grunbaum's-desire to have the Nanophor System
validated in a clinical	 or medical	 rnsear•ch laboratory.
.t
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LIQUID COOLED GARI;ENT "IEDICAL APPLIC TIONS
t 1	
-^
r
Objectives
To evaluate a -NASA-developed liquid  cooled garment in both research and
patient care applications at the Stanford University Medical 	 Center.
BatkgrOUnd
i
There is a need for better methods of lo ,.dering the body temperature of
patients being treated for a variety of medical 	 problems:
1.	 Hvpotherrria is	 gaining increasing acceptance in the
specialty of cardiovascular surgery. 	 Because lowering
the body temperature decreases metabolic rate and
oxygen consumption, hypotherrr ►ia has become an accepted A
.' alternative to cardiopulmonary bypass in the perfor-
rmance of open heart surgey on infants.
2.	 Surface cooling is being used prior to cardiopulmonary a
bypass (using the heart-Tung machine) 	 to allow reaching i
lo,  j body te^nperatur°es more	 rapidly. ;f
3.	 Lo:'rering body temperature has been sho-vin to have a
protective effect on patients with elevated intracranial
pressure and further research is being done in this
^k area
4.	 Better methods of controlling fever are needed in patients
frith_ infection or ,-;ho have-brain	 injury.	 Presently avail-
able
	
cooling bl anf.ets
	
are inadequate	 for these problems.
They do not provide  cl ose enough contact with a large a
^. enough bod y surface area to achieve the desired level of
_.^ coaling.	 In addition,	 it	 is difficult to	 regulate the
` temner•atUre of these cool-in( 	 blankets with the desired
,., degree o` control.
NASA Te chn ^ i on`/`
:. Liquid cooling ga rvents	 (LCG)	 have been developed within the space program
to protect astronauts	 fr-or,r adverse	 thermal	 conditions	 d ► ri nrl extra'-vehicular_
i^
)ctivity. Investigators at	 the ::'SA-,Amos RQsearch Center have made
I _
i- -62-
improvements on the original LCG's used during the Apollo missions.
These garment' s utilize a flexible polymer that has thousands of tiny
channels inscribed in it through which cold water is circulated. Close
contact wi th the body surface is maintained by incorporating panels made
from this material	 inside an elastic suit made of spandex.
}	 Piroject Status
Ames Research Center physiologists and engineers have met with doctors
I
at the Stanford University Medical School in the Departments of Neurosurgery
and Anesthesiology to specify requirements for a liquid cooled garment to
be usedin the four areas listed above.	 They have agreed upon a design
which allows	 continuous	 cooling of the patient tvi thout i nterferri ng with
thel routine nursing care. 	 The loan of a liquid cooled garment and its r
attendant refrigeration unit is anticipated during the spring of 1977.
In addition to the application. of LCG's at Stanford-University; 	 the
team is assisting Doctor 'Williams (at Ames)	 in coordinating the transfer
of this technology to breast thermography and cancer research.
Personnel
Ia
Principle Investigators:
	 Allen Ream, MJD.
i
Stanford University iedical
	 School
Ger a ld Silverberg,
Stanford University ;.edical
	 School
NAS % 'Engineers:
	 BrUCO Webbon,
1 .SA-.=m-;:s
	 Research Center~
Dill	 'Jilliarrs,
	 PhD
NASA--Nines Research Center i
BATeimi Coordinator:	 Robert Dabs
A
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sAPPENDIX A - COLLABORATING 11STITUTIONS
Thhe following is	 an alphabetical	 listing of non-NASA-institutioi7s	 thatz•
have been cooperating with the Stanford BATean on various biomedical <<
If
problem-solving activities	 during this	 reporting period:
1. Bureau of (Minds - Pittsburg, Pennsylvania
2. Children's Hospital
	
at Stanford -	 Palo Alto,	 California
3. Georgetown University Hospital	 - Washington D.C.
4. Harbor General	 Hospital - Los Angeles,	 California
5. Hershey Medical	 Center - Hershey, Pennsylvania
6'. Lawrence Radiation Laboratory - Berkeley, California
i
►
7. Los Gatos Community Hospital	 - Los Gatos, California
Louisiana State University - New Orleans, Louisiana
= 9. Santa Clara Valley Medical
	
Center - San Jose,	 California
10`. Stanford University School of Medicine - Stanford, California
1 L'. The National Cancer Institute - Bethesda, Maryland
12k University of Alabama - Birmingham,- Alabama
13. University of Arizona Medical	 Center - Tuscon, Arizona
r 14. University of Oklahoma Medical School 	 - Stillwater, Oklahoma
i
r
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APPENDIX 0 - MEDICAL DEVICE MANUFACTNERS
Below is a listing of medical 	 instrumentation manufacturers that are
working with the Stanford BATeam on the commercialization of technology
derived fromaerospace research and development:
1. Aerotherm Acurex -
405 Clyde Avenue
Mountain View, California	 94040
2. I'n Vivo Metric System
P.O. Box 217
{
Redwood Valley, California	 95470
3. Konigsberg Systems,	 Inc.
2000 East Foothill Boulevard _.
' Pasadena, California	 91107
4. L & M Electronics Company
2401 Geneva Avenue
Daly City, California	 94014
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